ENGINEERING AN EX-VIVO PERFUSION-BASED BIOREACTOR SYSTEM FOR DRUG-TESTING ON PATIENT-SPECIFIC CANCER SPECIMENS

被引：0
|
作者：
Muraro, Manuele Giuseppe [1 ,2 ]
Mazzoleni, Andrea [1 ,2 ]
Kabak, Evrim Ceren [1 ,2 ]
Scherberich, Arnaud [1 ,2 ]
Martin, Ivan [1 ,2 ]
机构：
[1] Univ Basel, Dept Biomed, Tissue Engn, Basel, Switzerland
[2] Univ Hosp Basel, Basel, Switzerland
来源：
TISSUE ENGINEERING PART A | 2022年 / 28卷
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
1033
引用
收藏
页码：S288 / S288
页数：1
相关论文
共 48 条
  • [21] Perfusion-based bioreactor culture of primary cancer tissue maintains tumor microenvironment complexity and allow in-vitro testing of immune blockade therapy
    Muraro, Manuele Giuseppe
    Muenst, Simone
    Manfredonia, Celeste
    Mele, Valentina
    Daester, Silvio
    Tzankov, Alexandar
    Terracciano, Luigi
    Weber, Walter
    Spagnoli, Giulio C.
    Iezzi, Giandomenica
    Martin, Ivan
    Soysal, Savas D.
    [J]. CANCER RESEARCH, 2017, 77
  • [22] Development and ex-vivo assessment of a novel patient specific guide and instrumentation system for minimally invasive total shoulder arthroplasty
    Giles, Joshua W.
    Broden, Cyrus
    Tempelaere, Christine
    Emery, Roger J. H.
    Rodriguez y Baena, Ferdinando
    [J]. PLOS ONE, 2021, 16 (05):
  • [23] Clinical translation pathway for identifying patient-specific dregs based on predictive simulation outcomes with ex vivo validation
    Doudican, Nicole Adell
    Vall, Shireen
    Meredith, Annette
    Talawdekar, Anay
    Kumar, Ansu
    Singh, Neeraj
    Tyagi, Anuj
    Kapoor, Shweta
    Sultana, Zeba
    Abbasi, Taher
    Mazumder, Amitabha
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Ex vivo drug testing in patient-derived pancreatic cancer organoids (PDOs) - challenges and potential applications
    Nollmann, F.
    Klar, R. F. U.
    Hussung, S.
    Devisme, A.
    Andrieux, G.
    Fritsch, K.
    Duyster, J.
    Wittel, U.
    Boerries, M.
    Fritsch, R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 292 - 292
  • [25] Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells
    Saeed, Khalid
    Ojamies, Poojitha
    Pellinen, Teijo
    Eldfors, Samuli
    Turkki, Riku
    Lundin, Johan
    Jarvinen, Petrus
    Nisen, Harry
    Taari, Kimmo
    af Hallstrom, Taija M.
    Rannikko, Antti
    Mirtti, Tuomas
    Kallioniemi, Olli
    Ostling, Paivi
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (06) : 1356 - 1366
  • [26] Bayesian inference for identifying tumour-specific cancer dependencies through integration of ex-vivo drug response assays and drug-protein profiling
    Hanwen Xing
    Christopher Yau
    [J]. BMC Bioinformatics, 25
  • [27] Bayesian inference for identifying tumour-specific cancer dependencies through integration of ex-vivo drug response assays and drug-protein profiling
    Xing, Hanwen
    Yau, Christopher
    [J]. BMC BIOINFORMATICS, 2024, 25 (01)
  • [28] Ovarian cancer ex vivo 3D tumor cultures predict patient specific drug sensitivity
    Grillet, Fanny
    Jariani, Abbas
    Overkamp, Juul
    Daszkiewicz, Lidia
    Yan, Kuan
    Price, Leo S.
    Vader, Willemijn
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [29] A system using patient-specific 3D-printed molds to spatially align in vivo MRI with ex vivo MRI and whole-mount histopathology for prostate cancer research
    Wu, Holden H.
    Priester, Alan
    Khoshnoodi, Pooria
    Zhang, Zhaohuan
    Shakeri, Sepideh
    Mirak, Sohrab Afshari
    Asvadi, Nazanin H.
    Ahuja, Preeti
    Sung, Kyunghyun
    Natarajan, Shyam
    Sisk, Anthony
    Reiter, Robert
    Raman, Steven
    Enzmann, Dieter
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2019, 49 (01) : 270 - 279
  • [30] Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer
    Nancy Gavert
    Yaara Zwang
    Roi Weiser
    Orli Greenberg
    Sharon Halperin
    Oded Jacobi
    Giuseppe Mallel
    Oded Sandler
    Adi Jacob Berger
    Erez Stossel
    Daniil Rotin
    Albert Grinshpun
    Iris Kamer
    Jair Bar
    Guy Pines
    Daniel Saidian
    Ilan Bar
    Shay Golan
    Eli Rosenbaum
    Andrei Nadu
    Eytan Ben-Ami
    Rony Weitzen
    Hovav Nechushtan
    Talia Golan
    Baruch Brenner
    Aviram Nissan
    Ofer Margalit
    Dov Hershkovitz
    Guy Lahat
    Ravid Straussman
    [J]. Nature Cancer, 2022, 3 : 219 - 231
12345